BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27184803)

  • 1. Course of Psychiatric Symptoms and Abstinence among Methamphetamine-Dependent Persons in Sober Living Recovery Homes.
    Polcin DL; Witbrodt J; Korcha R; Gupta S; Mericle AA
    J Psychoactive Drugs; 2016; 48(3):173-80. PubMed ID: 27184803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Trajectories of Psychiatric Symptoms Among Sober Living House Residents.
    Polcin D; Korcha R; Gupta S; Subbaraman MS; Mericle AA
    J Dual Diagn; 2016; 12(2):175-84. PubMed ID: 27082699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sober living houses for alcohol and drug dependence: 18-month outcomes.
    Polcin DL; Korcha RA; Bond J; Galloway G
    J Subst Abuse Treat; 2010 Jun; 38(4):356-65. PubMed ID: 20299175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopathology in methamphetamine-dependent adults 3 years after treatment.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson RA;
    Drug Alcohol Rev; 2010 Jan; 29(1):12-20. PubMed ID: 20078677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender Differences in Psychiatric Symptoms among Methamphetamine Dependent Residents in Sober Living Houses.
    Polcin DL; Buscemi R; Nayak M; Korcha R; Galloway G
    Addict Disord Their Treat; 2012 Jun; 11(2):53-63. PubMed ID: 23559891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of motivation and psychiatric symptoms on substance abuse outcomes in sober living houses.
    Polcin DL; Korcha RA; Bond JC
    Subst Use Misuse; 2015 Jan; 50(2):195-204. PubMed ID: 25290664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in psychiatric symptoms among persons with methamphetamine dependence predicts changes in severity of drug problems but not frequency of use.
    Polcin DL; Korcha R; Bond J; Galloway G; Nayak M
    Subst Abus; 2016; 37(1):209-14. PubMed ID: 25775225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile of psychiatric symptoms in methamphetamine users in China: Greater risk of psychiatric symptoms with a longer duration of use.
    Ma J; Sun XJ; Wang RJ; Wang TY; Su MF; Liu MX; Li SX; Han Y; Meng SQ; Wu P; Shi J; Bao YP; Lu L
    Psychiatry Res; 2018 Apr; 262():184-192. PubMed ID: 29453037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clean and sober place to live: philosophy, structure, and purported therapeutic factors in sober living houses.
    Polcin DL; Henderson DM
    J Psychoactive Drugs; 2008 Jun; 40(2):153-9. PubMed ID: 18720664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical course and outcomes of methamphetamine-dependent adults with psychosis.
    Glasner-Edwards S; Mooney LJ; Marinelli-Casey P; Hillhouse M; Ang A; Rawson R;
    J Subst Abuse Treat; 2008 Dec; 35(4):445-50. PubMed ID: 18294802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withdrawal symptoms in abstinent methamphetamine-dependent subjects.
    Zorick T; Nestor L; Miotto K; Sugar C; Hellemann G; Scanlon G; Rawson R; London ED
    Addiction; 2010 Oct; 105(10):1809-18. PubMed ID: 20840201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longer term improvement in neurocognitive functioning and affective distress among methamphetamine users who achieve stable abstinence.
    Iudicello JE; Woods SP; Vigil O; Scott JC; Cherner M; Heaton RK; Atkinson JH; Grant I;
    J Clin Exp Neuropsychol; 2010 Aug; 32(7):704-18. PubMed ID: 20198527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cognitive impairments and psychological wellbeing of methamphetamine dependent patients compared with health controls.
    Zhong N; Jiang H; Du J; Zhao Y; Sun H; Xu D; Li C; Zhuang W; Li X; Hashimoto K; Zhao M
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():31-7. PubMed ID: 27085943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social Support Influences on Substance Abuse Outcomes Among Sober Living House Residents with Low and Moderate Psychiatric Severity.
    Polcin DL; Korcha R
    J Alcohol Drug Educ; 2017 Apr; 61(1):51-70. PubMed ID: 28757663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month length of stay associated with better recovery outcomes among residents of sober living houses.
    Subbaraman MS; Mahoney E; Mericle A; Polcin D
    Am J Drug Alcohol Abuse; 2023 Sep; 49(5):675-683. PubMed ID: 37782760
    [No Abstract]   [Full Text] [Related]  

  • 16. Hostility among methamphetamine users experiencing psychotic symptoms.
    McKetin R; McLaren J; Lubman DI; Hides L
    Am J Addict; 2008; 17(3):235-40. PubMed ID: 18464001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The profile of psychiatric symptoms exacerbated by methamphetamine use.
    McKetin R; Dawe S; Burns RA; Hides L; Kavanagh DJ; Teesson M; McD Young R; Voce A; Saunders JB
    Drug Alcohol Depend; 2016 Apr; 161():104-9. PubMed ID: 26874915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes Among Sober Living House Residents Who Relapse: Role of Recovery Capital.
    Polcin DL; Mahoney E; Witbrodt J; Subbaraman M; Mericle AA
    J Psychoactive Drugs; 2024; 56(3):433-441. PubMed ID: 37326458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Housing Status, Psychiatric Symptoms, and Substance Abuse Outcomes Among Sober Living House Residents over 18 Months.
    Polcin DL; Korcha R
    Addict Disord Their Treat; 2017 Sep; 16(3):138-150. PubMed ID: 29056875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and Neighborhood Correlates of Sober Living House Locations in Los Angeles.
    Mericle AA; Karriker-Jaffe KJ; Gupta S; Sheridan DM; Polcin DL
    Am J Community Psychol; 2016 Sep; 58(1-2):89-99. PubMed ID: 27628590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.